Can pulmonary fibrosis be mistaken for conditions like COPD or asthma? 

It is common for pulmonary fibrosis to be mistaken for more well-known respiratory conditions such as asthma or Chronic Obstructive Pulmonary Disease (COPD). Because the early signs of lung scarring primarily breathlessness and a persistent cough overlap significantly with these more common illnesses, many patients in the UK are initially treated for obstructive airway diseases before the correct diagnosis is reached. However, while the symptoms may appear similar, the underlying cause and the required medical treatments are fundamentally different. Recognising these differences is vital for ensuring that patients with lung scarring receive the correct specialist care and access to treatments that can slow the progression of the disease. 

What We’ll Discuss in This Article 

• Why symptoms of breathlessness and cough overlap across conditions. 

• The difference between “obstructive” and “restrictive” lung diseases. 

• How a physical examination helps a GP distinguish between these illnesses. 

• The role of diagnostic imaging in ruling out asthma or COPD. 

• Why a correct diagnosis is essential for effective treatment planning. 

The challenge of overlapping symptoms 

In the early stages of pulmonary fibrosis, the symptoms are often subtle and non-specific. Shortness of breath during physical activity is a hallmark of pulmonary fibrosis, but it is also a primary symptom of both asthma and COPD. Similarly, a persistent cough can be present in all three conditions. Because asthma and COPD are much more common in the UK, they are often the first conditions a GP will consider. It is not unusual for a patient with pulmonary fibrosis to be initially prescribed an inhaler to see if their symptoms improve. If the symptoms do not resolve with standard asthma or COPD treatments, it is an important signal to healthcare professionals that further investigation into the lung tissue itself is required. 

Obstructive versus restrictive lung patterns 

One of the most significant differences between these conditions is how they affect the lungs’ physical function. Asthma and COPD are classified as “obstructive” diseases, meaning the primary problem is that the airways are narrowed or blocked, making it difficult to blow air out quickly. Pulmonary fibrosis, on the other hand, is a “restrictive” disease. In pulmonary fibrosis, the lungs become stiff and scarred, which reduces the total amount of air the lungs can hold. This means the lungs are restricted from expanding fully. While an asthma patient might struggle to exhale, a patient with pulmonary fibrosis struggles to take a full, deep breath because the lung tissue has lost its elasticity. 

Distinguishing features during examination 

A simple physical examination can provide a UK doctor with vital clues that help distinguish pulmonary fibrosis from other conditions. When listening to the chest of a patient with asthma or COPD, a doctor often hears “wheezing,” which is a whistling sound caused by narrowed airways. In contrast, the most common sound heard in pulmonary fibrosis is “crackles.” Specialists often describe these as “Velcro crackles” because they sound remarkably like a strip of Velcro being pulled apart. These crackles are caused by the stiffened air sacs snapping open as the person inhales. Additionally, physical signs like finger clubbing are common in pulmonary fibrosis but are rarely seen in simple asthma or COPD. 

Feature	Pulmonary Fibrosis	Asthma / COPD
Primary Issue	Stiff, scarred lung tissue (Restricted)	Narrowed or blocked airways (Obstructed)
Lung Sounds	Fine, dry crackles (Velcro sounds)	Wheezing or whistling sounds
Cough Type	Usually dry and non-productive	Can be dry (asthma) or chesty (COPD)
Physical Signs	Finger clubbing common	Clubbing is rare
Symptom Speed	Gradually worsens over years	Can flare up suddenly (attacks)

The role of diagnostic testing 

To confirm the diagnosis and rule out other conditions, UK specialists rely on a combination of breathing tests and imaging. A test called spirometry is used to measure the “shape” of a person’s breathing. If the results show that the lungs are small but the air moves out at a normal speed, it points toward a restrictive condition like fibrosis rather than an obstructive one like COPD. However, the definitive way to distinguish between these conditions is a high-resolution CT (HRCT) scan. While a person with asthma may have a completely normal CT scan, a patient with pulmonary fibrosis will show clear patterns of scarring and structural damage that are not present in obstructive airway diseases. 

Why an accurate diagnosis is vital 

Reaching the correct diagnosis is essential because the medications used for asthma and COPD, such as steroid inhalers or bronchodilators, do not treat the underlying scarring in pulmonary fibrosis. Conversely, the antifibrotic medications used for idiopathic pulmonary fibrosis are not appropriate for people with obstructive conditions. In the UK, the NHS uses a multidisciplinary team (MDT) approach to review all test results, ensuring that the diagnosis is accurate before a long-term treatment plan is started. This collaborative expert review is the best way to ensure that a patient is not misdiagnosed with a more common condition and misses out on the specialised support they need. 

Conclusion 

Pulmonary fibrosis is frequently mistaken for asthma or COPD due to the similarity of their early symptoms. However, the physical signs such as Velcro-like crackles and a restrictive breathing pattern help specialists in the UK distinguish lung scarring from obstructive airway diseases. Accurate diagnosis via high-resolution CT scans and expert multidisciplinary review is a critical step in ensuring patients receive the correct medication and support. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article explores the clinical differences between pulmonary fibrosis and more common conditions like asthma and COPD, ensuring all information is aligned with the standards of the NHS and NICE. The goal is to provide a clear and reliable overview of the diagnostic process used in UK respiratory medicine. This content has been produced by a medical content team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician, to maintain clinical accuracy.